Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2016 by Jonsson Comprehensive Cancer Center
Sponsor:
Collaborator:
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Jonsson Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT01345136
First received: April 21, 2011
Last updated: August 23, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2017
  Estimated Primary Completion Date: February 2017 (Final data collection date for primary outcome measure)